Pharma & Bio
Lifestyle
[Exclusive] Remedy Confirms Supply of Portable X-ray and Ultrasound Devices to the U.S. AMA… "AI-Powered Remote Diagnosis Breaks into the U.S. Market"
#Remedy, a company specializing in ultra-compact X-ray technology, has secured a contract to supply its equipment to the American Medical Administrators (AMA), a U.S. healthcare services group, and is…
- 2026-09-04 08:06:03
- YU JIN-HEE
Technology
Yoon Ji-hyun, CEO of Willog: "Sensor Data Is the New Language of Insurance; It Will Transform the Pharmaceutical Cold Chain"
The pharmaceutical cold chain (low-temperature distribution system) logistics process has long been referred to as a “black box.” In the pharmaceutical and biotech logistics sector, there have been re…
- 2026-09-03 11:02:02
- Kim Seung-kwon
Technology
'500% Surge': Wall Street Is Obsessed with This Hair Loss Treatment… "The Next Gold Mine After Obesity Drugs" [Bio Spotlight]
Following obesity treatments, hair loss treatments are emerging as a new investment opportunity in global stock markets. In South Korea as well, related stocks have surged on expectations that hair lo…
- 2026-09-03 08:52:03
- NA EUN-KYUNG
Technology
Hair-Loss Stocks Rally, Peptron Falls as Lilly Deadline Nears [K-Bio Pulse]
Hair-loss treatments are emerging as a new investment theme in global stock markets following the obesity drug boom. In South Korea, expectations for expanded national health insurance coverage have s…
- 2026-09-03 08:52:03
- NA EUN-KYUNG
Business·Industry
[Noul Co., Ltd. Deep Dive ①] The Story Behind the 21.2 Billion Won Order Backlog… Cumulative Deliveries at 19%—Not Confirmed Revenue
Noul Co., Ltd.(376930), a company specializing in AI-based diagnostic platforms, had an order backlog of 21.2 billion won at the end of the first half of this year, but the amount actually delivered t…
- 2026-09-03 08:52:02
- KIM SAE-MI
Technology
1 Trillion Yen Botulinum Toxin Market... Daewoong and Medytox Race to Secure Official Approval
#Daewoong Pharmaceutical has begun the process of seeking formal approval for its botulinum toxin “Nabota” (DWP450) in the Japanese market. Given Japan’s regulatory framework, which permits the use of…
- 2026-09-03 08:07:02
- KIM SUNG-JIN
Technology
[Report] “AI Eyes” Appear on the Ketotop Production Line… The Evolving HANDOK Inc. Voice Factory
Seo Eui-yeon, Head of the Production Support Office at HANDOK Inc., explains the solid dosage form production process on a screen displaying equipment linked to digital data at the HANDOK Eumseong Pro…
- 2026-09-03 08:02:02
- Minji Son
Lifestyle
HLB INC.’s Second Promising Drug, ‘Lirapugratinib’: The Fate of Its U.S. Approval [Monthly Insight]
The most notable issue in the pharmaceutical and biotech industry this September is HLB INC.(028300)’s second attempt to gain approval in the U.S. HLB is awaiting approval from the U.S. Food and Drug …
- 2026-09-03 07:01:03
- Kim Jinsoo
Technology
CHONGKUNDANG Takes the Lead in Domestic Development of New U.S. Retinal Drug… Expanding into Rare Eye Diseases
(Graphic: ChatGPT)
CHONGKUNDANG(185750)is embarking on the development of a new drug for rare eye diseases by acquiring “KIO-301,” a new drug candidate for retinal diseases from U.S.-based Kiora P…
- 2026-09-03 07:01:02
- Minji Son
Technology
Kim Ju-hee, CEO of Inventage Lab Inc.: “SC Formulation Platform Signs MTAs with Multiple Domestic Companies... Begins Validation of Actual Antibodies”
Inventage Lab Inc.(389470)The company has begun technical validation of its next-generation subcutaneous (SC) formulation modification platform, “IVL-BioFluidic™.” It has signed Material Transfer Agre…
- 2026-09-02 11:47:01
- NA EUN-KYUNG
PHARM EDAILY
Shorts